[go: up one dir, main page]

TR201007652A2 - Sinerjik etki. - Google Patents

Sinerjik etki.

Info

Publication number
TR201007652A2
TR201007652A2 TR2010/07652A TR201007652A TR201007652A2 TR 201007652 A2 TR201007652 A2 TR 201007652A2 TR 2010/07652 A TR2010/07652 A TR 2010/07652A TR 201007652 A TR201007652 A TR 201007652A TR 201007652 A2 TR201007652 A2 TR 201007652A2
Authority
TR
Turkey
Prior art keywords
synergistic effect
acetylcysteine
sedative
generation
invention includes
Prior art date
Application number
TR2010/07652A
Other languages
English (en)
Turkish (tr)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2010/07652A priority Critical patent/TR201007652A2/xx
Priority to PCT/TR2011/000213 priority patent/WO2012039691A2/en
Publication of TR201007652A2 publication Critical patent/TR201007652A2/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
TR2010/07652A 2010-09-20 2010-09-20 Sinerjik etki. TR201007652A2 (tr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2010/07652A TR201007652A2 (tr) 2010-09-20 2010-09-20 Sinerjik etki.
PCT/TR2011/000213 WO2012039691A2 (en) 2010-09-20 2011-09-20 Synergic effect

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2010/07652A TR201007652A2 (tr) 2010-09-20 2010-09-20 Sinerjik etki.

Publications (1)

Publication Number Publication Date
TR201007652A2 true TR201007652A2 (tr) 2012-04-24

Family

ID=45034153

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2010/07652A TR201007652A2 (tr) 2010-09-20 2010-09-20 Sinerjik etki.

Country Status (2)

Country Link
TR (1) TR201007652A2 (xx)
WO (1) WO2012039691A2 (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106109422A (zh) * 2016-07-28 2016-11-16 北京万全德众医药生物技术有限公司 盐酸左西替利嗪泡腾颗粒及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3184505A (en) 1962-06-18 1965-05-18 Mead Johnson & Co Process for the n-monoacylation of cysteine
FI75816C (fi) 1981-02-06 1988-08-08 Ucb Sa Foerfarande foer framstaellning av terapeutiskt aktiv 2-/4-(difenylmetyl)-1-piperazinyl/-aettiksyror eller dess amid.
WO1985003707A1 (en) 1984-02-15 1985-08-29 Schering Corporation 8-CHLORO-6,11-DIHYDRO-11-(4-PIPERIDYLIDENE)-5H-BENZO AD5,6 BDCYCLOHEPTA AD1,2-b BDPYRIDINE AND ITS SALTS, PROCESSES FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS
GB8827391D0 (en) 1988-11-23 1988-12-29 Ucb Sa Process for preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-pipera-zinyl)ethoxy)-acetic acid & its dihydrochloride
ATE170749T1 (de) 1992-09-24 1998-09-15 Sepracor Inc Verwendung von (-) cetirizin zur behandlung allergischer rhinitis und und asthma
WO2001085148A2 (en) * 2000-05-05 2001-11-15 Aventis Pharmaceuticals Inc. Packaging regimen of pseudoephedrine hydrochloride and fexofenadine hydrocloride
US7955620B2 (en) * 2003-12-23 2011-06-07 Sun Pharmaceutical Industries Limited Stable oral composition
US20080139654A1 (en) * 2006-12-09 2008-06-12 Eric Mott Soderling Acetaminophen compositions having minimized side effects including reduced hepatotoxicity

Also Published As

Publication number Publication date
WO2012039691A3 (en) 2012-05-18
WO2012039691A2 (en) 2012-03-29

Similar Documents

Publication Publication Date Title
CY1121390T1 (el) Πυρρολοβενζοδιαζεπινες και συζευγματα αυτων
PH12013500065A1 (en) Deuterated n-ethyl-n-phenyl-1,2-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide, salts and uses thereof
CL2012002979A1 (es) Derivados de n3-sustituido-n1-sulfonil-5-fluorpirimidinona.
BR112013031361A2 (pt) galactomanana cationicamente e anfifilicamente modificada, e, composição
GB2506783A (en) Enabling a computing device to utilize another computing device
TR201907828T4 (tr) Geni̇ş spektrumlu bi̇r anti̇-mi̇krobi̇yel ajan
BR112015019647A2 (pt) criação de perfil de caminho com uso de combinação de hardware e software.
IT1399905B1 (it) Struttura tessile laminare, particolarmente idonea per componenti acustici.
DK2568854T3 (da) Sædeindretning
EP3011430A4 (en) Unifying application log messages using runtime instrumentation
UY4223Q (es) Banco
TR201904120T4 (tr) Konnektör parçası.
CL2009001973S1 (es) Mostrador.
EP2710024A4 (en) OSW-1 ANALOGA AND CONJUGATES AND ITS USE
FR2964411B1 (fr) Aube de turboreacteur, notamment une aube de redresseur, et turboreacteur recevant de telles aubes
UY4243Q (es) Banco
TR200903176A1 (tr) Çoklu blister.
TR201007652A2 (tr) Sinerjik etki.
IT1399443B1 (it) Indumento intimo.
IT1399581B1 (it) Dispositivo per la protezione di parti del corpo di un individuo, in particolare per la protezione della schiena.
TR201900608T4 (tr) Bir hava hazırlama cihazına sahip olan davlumbaz cihazı.
TR201005220U (tr) Kabloların sevkiyatı için kullanılan makaralarda yenilik.
TN2010000567A1 (fr) المحطة الكهرمائية الشمسية
TN2010000017A1 (fr) مستحضر تجميلي دوائي
ES1074160Y (es) Bandeja posterior enrollable con doble apertura para automovil.